Scientific Commercialization Continues to Bolster Compliance Practice for Medical Affairs and Beyond

cbi

In November, Art Kerwin J.D., Scientific Commercialization (SC) Consultant, attended CBI’s Annual Compliance Conference. CBI provides thought leadership, actionable data, benchmarking, case studies, and regulatory information for life sciences companies through conference platforms across the pharmaceutical, biotechnology, medical device and healthcare industries.

To read the complete post, use the link below to view and/or download.

Scientific Commercialization Continues to Bolster Compliance Practice for Medical Affairs and Beyond

Leave a Reply

Your email address will not be published. Required fields are marked *